FDA Perspective on Rare Diseases
Rich Moscicki, M.D., Deputy Center Director for Science Operations, FDA spoke to…
Health Economics and Outcomes Research: Why a Wise Manufacturer Should Think of It Early and Often
Guest Post from Marya Zilberberg, MD, MPH Guest Post from Marya Zilberberg,…
Crowd-Sourcing in Clinical Development
Guest Post from Tomasz Sablinski, MD, PhD FDA’s Janet Woodcock recently…
